Skip to content
Medical Health Aged Care

Australia needs to work on its health literacy to stay in top shape

RMIT University 2 mins read

Topics: digital health literacy, health literacy, healthcare, health policy, healthy living

Professor Kerryn Butler-Henderson, Director of Digital Health at RMIT University

“From pedometers, smartwatches to telehealth technologies, we’ve been relying on digital tools to help make health decisions for decades. The pandemic highlighted how important it was to understand health information and to know when something might be misinformation or disinformation.

“The same is true about digital health tools. We need to learn how to tell when a technology is safe to use, to understand what happens to your health data when it is captured in health technology, and how to interpret the data to be in greater control of our own health.

“Government, health services and health practitioners all play a role in providing the health literacy of our citizens – this starts with our school-aged children.

“We need to focus on educating our young people so they understand the importance of health data, information and technology.

“More needs to be done to address barriers preventing access for marginalised communities, including older Australians and people from culturally and linguistically diverse backgrounds.

“But we need more research studies to track our progress in this area and this could be helped by governments funding more studies and working towards targets.

“Ways we can be more health literate include taking an active role in your health, care and wellness.

“Ask your health provider questions and ask for resources to learn more about your health.

“Find a reliable source that you can trust for health information, such as a government website or a credible peak body that bases its information on peer reviewed published evidence.

“Read the reviews on health applications and technology before you use them and look to your local government for initiatives to skill up your leadership in your health and wellness goals."

Professor Kerryn Butler-Henderson is the Director of Digital Health at RMIT University. Kerryn recently contributed to the European Union-funded Global Atlas of Literacies for Health, one of the first interactive tools visualising levels of health and digital health literacy from evidence-based studies conducted with residents in Europe and beyond.

Contact details:

Interviews: Professor Kerryn Butler-Henderson 0408 956 082 or

General enquiries: General enquiries: 0439 704 077 or 

More from this category

  • Medical Health Aged Care
  • 30/11/2023
  • 06:05
Royal Australian College of GPs

RACGP calls on Queensland to reduce pressure on hospitals and improve the health of Queenslanders

As Queensland hospitals grapple with devastating ramping, bed shortages, and delays, there has never been a more crucial time for the state to invest in general practice to keep people healthy in the community, says the Royal Australian College of GPs (RACGP). A perfect storm of factors, including an aging population, epidemic of chronic disease, and acute workforce shortages, is putting increasing pressure on Queensland’s hospitals, prompting the RACGP to make its first Budget submission to the state government. RACGP Queensland Chair Dr Cathryn Hester said investment in general practice is key to reducing pressure on Queensland's hospital system. “Queensland’s…

  • General News, Medical Health Aged Care
  • 30/11/2023
  • 06:00
UNSW Sydney

Meet Viv: an AI character fostering companionship for people with dementia

With a view to improving the lives of people living with dementia, UNSW researchers have come up with a world-first: an AI driven companion.…

  • Contains:
  • Medical Health Aged Care
  • 29/11/2023
  • 23:22
Clairvoyant Therapeutics

Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

VANCOUVER, BC / ACCESSWIRE / November 29, 2023 / Clairvoyant Therapeutics Inc. (, the clinical-stage pharmaceutical company developing psilocybin therapy for alcohol use disorder (AUD), today announced that it has randomized more than 50 per cent of the expected 128 subjects for its 24-week Phase 2b clinical trial of synthetic psilocybin (25mg oral capsule). The double-blind, randomized controlled trial was initiated in October 2022 and is designed to assess multiple efficacy and safety endpoints."We are pleased that the pace of subject enrollment is at the upper end of our expectations. We are on track for an interim data read out…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.